DLEU7

Model summary

A soluble human adaptor that assembles trafficking and cytoskeletal modules to regulate vesicle pathways and organelle dynamics. It operates primarily in the cytoplasm and cytosol, with regulated access to the nucleoplasm and enrichment at the centrosome, where it scaffolds factors that coordinate microtubule organization and membrane remodeling. Through multivalent protein binding, it likely tunes cargo sorting and acrosome-related pathways that are especially important during germ-cell development, thereby contributing to spermatogenesis.

Predicted Gene Ontology terms

1. 01

   I begin with the InterPro architecture: IPR031510 (Leukemia-associated protein 7 family) spans residues 1–221 and covers the entire polypeptide.

   A single full-length family signature without embedded catalytic domains indicates a non-enzymatic adaptor/scaffold. LAP-7/LAMPT family proteins typically present extended, often coiled-coil–rich architectures that create multivalent protein–protein interfaces rather than active sites. This architecture causally supports a molecular role centered on assembling and positioning other factors, which aligns with GO:0005515 protein binding as the primary molecular function.

2. 02

   From this scaffold-like core, I infer function by mapping where and how such an adaptor operates.

   The LAP-7 family is known to concentrate at cytoskeletal organizing centers and membrane-proximal compartments. The explicit cellular component evidence points to the cytoplasm and cytosol (GO:0005737 cytoplasm; GO:0005829 cytosol), with additional enrichment at the nucleoplasm (GO:0005654 nucleoplasm) and the centrosome (GO:0005813 centrosome). A soluble adaptor that shuttles between cytosol and nucleoplasm and accumulates at the centrosome is well positioned to coordinate vesicle trafficking and microtubule-organizing activities. This spatial logic explains how a non-catalytic scaffold can still drive specific pathways: by recruiting and stabilizing effectors that control cargo sorting and organelle dynamics.

3. 03

   The biological process evidence converges on spermatogenesis (GO:0007283 spermatogenesis).

   A centrosome- and cytosol-enriched adaptor can regulate germ-cell-specific trafficking and cytoskeletal remodeling that underpin meiosis and spermiogenesis. Its soluble nature and family identity support a role in germ-cell vesicle pathways and acrosome-related biogenesis, which are tightly coupled to centrosomal functions and nuclear-cytoplasmic exchange.

4. 04

   The subcellular location label “Cytoplasm” further reinforces a soluble, non-membrane-embedded role that dynamically samples cytosolic and nucleoplasmic pools.

   The centrosome association provides a mechanistic anchor: centrosomal scaffolds nucleate microtubule arrays and interface with endosomal and secretory routes that many cell types, including germ cells, use for polarized transport and membrane remodeling.

5. 05

   Putting these strands together, I propose the following mechanism.

   The LAP-7 family domain architecture creates a multivalent binding platform that assembles trafficking and cytoskeletal modules in the cytosol and at the centrosome. By concentrating effectors of vesicle formation and cargo selection, the adaptor modulates pathways that are particularly critical during spermatogenesis. Transient nucleoplasmic residency suggests regulated shuttling—potentially coupling trafficking status to transcriptional or chromatin-associated checkpoints in germ cells.

6. 06

   This model predicts interaction partners that match the adaptor’s locale and function: centrosomal organizers (e.g., pericentriolar matrix and γ-tubulin complexes), microtubule motors and adaptors, and membrane-trafficking assemblies.

   In germ cells, associations with acrosome/secretory pathway machinery and nuclear-cytosolic regulators would be especially pronounced, coherently explaining the observed roles in spermatogenesis and the cytosol–centrosome–nucleoplasm itinerary.